IDEAYA Biosciences, Inc.
IDYA
$33.09
$0.260.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -83.27M | 119.24M | -77.49M | -72.18M | -130.31M |
| Total Depreciation and Amortization | 1.20M | 1.03M | 1.23M | 1.13M | 643.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.27M | 10.24M | 9.18M | 6.46M | 4.57M |
| Change in Net Operating Assets | -18.69M | 11.71M | 4.61M | 4.24M | 3.45M |
| Cash from Operations | -90.50M | 142.21M | -62.47M | -60.34M | -121.66M |
| Capital Expenditure | -333.00K | -42.00K | -663.00K | -1.33M | -1.10M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -97.19M | 41.81M | 46.58M | 81.15M | -196.01M |
| Cash from Investing | -97.53M | 41.77M | 45.92M | 79.82M | -197.11M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.13M | 301.00K | 1.21M | 26.14M | 2.75M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 2.13M | 301.00K | 1.21M | 26.14M | 2.75M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -185.89M | 184.28M | -15.35M | 45.62M | -316.01M |